These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 26579438)

  • 1. Metabolic effects of intestinal absorption and enterohepatic cycling of bile acids.
    Ferrebee CB; Dawson PA
    Acta Pharm Sin B; 2015 Mar; 5(2):129-34. PubMed ID: 26579438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bile acid nuclear receptor FXR and digestive system diseases.
    Ding L; Yang L; Wang Z; Huang W
    Acta Pharm Sin B; 2015 Mar; 5(2):135-44. PubMed ID: 26579439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased bile acids in enterohepatic circulation by short-term calorie restriction in male mice.
    Fu ZD; Klaassen CD
    Toxicol Appl Pharmacol; 2013 Dec; 273(3):680-90. PubMed ID: 24183703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influences of cholecystectomy on the circadian rhythms of bile acids as well as the enterohepatic transporters and enzymes systems in mice.
    Zhang F; Duan Y; Xi L; Wei M; Shi A; Zhou Y; Wei Y; Wu X
    Chronobiol Int; 2018 May; 35(5):673-690. PubMed ID: 29381405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bile acids and sphingosine-1-phosphate receptor 2 in hepatic lipid metabolism.
    Kwong E; Li Y; Hylemon PB; Zhou H
    Acta Pharm Sin B; 2015 Mar; 5(2):151-7. PubMed ID: 26579441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bile acids are nutrient signaling hormones.
    Zhou H; Hylemon PB
    Steroids; 2014 Aug; 86():62-8. PubMed ID: 24819989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bile acids contribute to the development of non-alcoholic steatohepatitis in mice.
    Gillard J; Clerbaux LA; Nachit M; Sempoux C; Staels B; Bindels LB; Tailleux A; Leclercq IA
    JHEP Rep; 2022 Jan; 4(1):100387. PubMed ID: 34825156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triglycerides and gallstone formation.
    Smelt AH
    Clin Chim Acta; 2010 Nov; 411(21-22):1625-31. PubMed ID: 20699090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of energy metabolism by long-chain fatty acids.
    Nakamura MT; Yudell BE; Loor JJ
    Prog Lipid Res; 2014 Jan; 53():124-44. PubMed ID: 24362249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of farnesoid X receptor and bile acids in alcoholic liver disease.
    Manley S; Ding W
    Acta Pharm Sin B; 2015 Mar; 5(2):158-67. PubMed ID: 26579442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bile acid coordinates microbiota homeostasis and systemic immunometabolism in cardiometabolic diseases.
    Guan B; Tong J; Hao H; Yang Z; Chen K; Xu H; Wang A
    Acta Pharm Sin B; 2022 May; 12(5):2129-2149. PubMed ID: 35646540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Editor's Highlight: Clofibrate Decreases Bile Acids in Livers of Male Mice by Increasing Biliary Bile Acid Excretion in a PPARĪ±-Dependent Manner.
    Zhang Y; Lickteig AJ; Csanaky IL; Klaassen CD
    Toxicol Sci; 2017 Dec; 160(2):351-360. PubMed ID: 28973556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. n-3 Fatty Acids Abrogate Dyslipidemia-Induced Changes in Bile Acid Uptake, Synthesis, and Transport in Young and Aged Dyslipidemic Rats.
    Acharya P; Talahalli RR
    Lipids; 2019 Jan; 54(1):39-51. PubMed ID: 30740707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Current Understanding of Bile Acids in Chronic Liver Disease.
    Farooqui N; Elhence A; Shalimar
    J Clin Exp Hepatol; 2022; 12(1):155-173. PubMed ID: 35068796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bile acid homeostasis in female mice deficient in
    Rizzolo D; Kong B; Taylor RE; Brinker A; Goedken M; Buckley B; Guo GL
    Acta Pharm Sin B; 2021 Dec; 11(12):3847-3856. PubMed ID: 35024311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roux-en-Y Gastric Bypass Improves Metabolic Conditions in Association with Increased Serum Bile Acids Level and Hepatic Farnesoid X Receptor Expression in a T2DM Rat Model.
    Yan Y; Sha Y; Huang X; Yuan W; Wu F; Hong J; Fang S; Huang B; Hu C; Wang B; Zhang X
    Obes Surg; 2019 Sep; 29(9):2912-2922. PubMed ID: 31079286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bile acid transporters: structure, function, regulation and pathophysiological implications.
    Alrefai WA; Gill RK
    Pharm Res; 2007 Oct; 24(10):1803-23. PubMed ID: 17404808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The human Na+-taurocholate cotransporting polypeptide gene is activated by glucocorticoid receptor and peroxisome proliferator-activated receptor-gamma coactivator-1alpha, and suppressed by bile acids via a small heterodimer partner-dependent mechanism.
    Eloranta JJ; Jung D; Kullak-Ublick GA
    Mol Endocrinol; 2006 Jan; 20(1):65-79. PubMed ID: 16123152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The coming of age of our understanding of the enterohepatic circulation of bile salts.
    Redinger RN
    Am J Surg; 2003 Feb; 185(2):168-72. PubMed ID: 12559450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enterohepatic bile salt transporters in normal physiology and liver disease.
    Kullak-Ublick GA; Stieger B; Meier PJ
    Gastroenterology; 2004 Jan; 126(1):322-42. PubMed ID: 14699511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.